Assessment of Lung Function (Lufu) at Sea Level LA vs. High Altitude HA in Patients With Pulmonary Arterial Hypertension PAH

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
To study the effect of a re-ascent to high altitude (Quito Ecuador: 2850m) after a one-week stay at sea level (after prior descent from 2850m) on lung function and pulmonary resistance/reactance in patients with pulmonary arterial disease PAH, who live permanently \> 2600m.
Epistemonikos ID: 74511ac2681d26387d8a52f6bc85e9662eeb802f
First added on: Sep 05, 2026